Initiate is hosting a catch-up event on the 24th of September at the JCA and NICE conferences.

With decades of experience in global Market Access and HEOR consultancy, we serve clients who need to achieve the best access outcome. By combining the optimal mix of knowledge, experience and capability across pharmaceuticals, medical devices and diagnostics and with specialist expertise in advanced gene and cell therapies for rare disorders, we guide and support our clients working with novel products aimed at helping those with life-limiting disease. In 2026, Initiate and Dark Peak Analytics came together, combining our people, expertise and capabilities to create a more integrated, end-to-end offering across market access, HEOR and analytics, and a stronger platform for future growth.